<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00595478</url>
  </required_header>
  <id_info>
    <org_study_id>85846</org_study_id>
    <secondary_id>1R01AA016917-01</secondary_id>
    <secondary_id>1R01AA016917-02</secondary_id>
    <secondary_id>1R01AA016917-03</secondary_id>
    <nct_id>NCT00595478</nct_id>
  </id_info>
  <brief_title>Family Based Contingency Management for Adolescent Alcohol Abuse</brief_title>
  <official_title>Family Based Contingency Management for Adolescent Alcohol Abuse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal is to adapt the family-based CM treatment to target primary adolescent alcohol abuse
      and dependence.

      Specific Aim 1 is to provide a preliminary demonstration of the efficacy of a family-based CM
      intervention to treat adolescent alcohol abuse and dependence. CM components include:

        1. an incentive program to enhance the adolescent's engagement in the treatment process and
           engender alcohol abstinence by providing positive reinforcement for documented
           abstinence via breathalyzers administered by parents regularly at home, self and parent
           report, and clinic-based urine drug testing; and

        2. a parent management training program to enhance and maintain the positive effects of the
           incentive program by teaching parents how to effectively use contingency management in
           the home environment to motivate their adolescent to achieve abstinence and improve
           their behavior in other domains.

      A randomized trial will determine whether the CM intervention enhances outcomes when added to
      a standard individual cognitive behavioral therapy (CBT).

      Specific Aim 2 is to determine whether and how treatment interventions modify parental and
      adolescent risk and protective factors using observational and laboratory measures (parenting
      practices, family functioning, risk taking, delay discounting, and child and parent
      psychopathology) and to determine whether these factors are associated with outcomes over
      time.

      Specific Aim 3 is to test gene x environment (treatment) interactions in adolescent substance
      abuse. Findings will extend the scientific evidence for CM and support the ability of parents
      to implement CM at home. Findings that support the CM model's efficacy will make a
      significant contribution to research on the treatment of adolescent alcohol abuse, which has
      lagged behind research on adult substance abuse and on adolescent illicit drug use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 1.5 million youth ages 12-17 (representing 6.1% of all youth in that age range)
      are in need of treatment for alcohol abuse, yet only 7.2% of those in need of treatment
      received it. Importantly, most youth (90.5%) who were classified as needing treatment based
      on their self report of Adolescent Alcohol Study Plan; v.2; 3/30/12Page 2 of 35 symptoms,
      perceived no need for treatment. Thus, there is a need to develop treatments that target
      populations of alcohol abusing youth who are not highly motivated to change their substance
      use. New outpatient family based and contingency management interventions for adolescent
      marijuana abuse have been developed, yet none of these interventions has specifically
      targeted adolescent alcohol use. It is important to target primary alcohol abuse and
      dependence in adolescence as approximately 20% of treatment-seeking youth report primary
      problems with alcohol. The primary aim of this proposal is to adapt our family-based
      contingency-management treatment to target adolescent alcohol abuse and dependence. This
      project will develop, manualize, and pilot a contingency management intervention that
      includes two components. First, an incentive program will enhance the adolescent's engagement
      in the treatment process and engender alcohol abstinence by providing positive reinforcement
      for documented abstinence via breathalyzers administered by parents regularly at home, self
      and parent report, and clinic based urine drug testing. Second, a parent management training
      program will enhance and maintain the positive effects of the incentive program by teaching
      parents how to effectively use contingency management in the home environment to motivate
      their adolescent to achieve abstinence and improve their behavior in other domains.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alcohol Abstinence</measure>
    <time_frame>Weekly up to 14 weeks</time_frame>
    <description>Number of non-abstinent urinalysis (ETG-positive) samples during 14 weeks of treatment (considering missing samples as non-abstinent)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days of Alcohol Use During 36-week Follow-up Period</measure>
    <time_frame>Monthly up to 9 months (36 weeks)</time_frame>
    <description>Percentage of days alcohol used during the 36-week follow-up period after treatment ended measured via timeline follow-back.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Alcohol Abuse</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Motivational Enhancement Therapy (MET)/CBT</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Enhancement Therapy (MET)/CBT+CM</intervention_name>
    <description>Behavioral Treatment</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Enhancement Therapy (MET)/CBT</intervention_name>
    <description>Behavioral Treatment</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  12-18 years old (if 18, must attend high school and live at home)

          -  Report using alcohol during the previous 30 days

          -  Have a parent/guardian who can participate

          -  Meet DSM criteria for either Alcohol Abuse or Dependence

          -  Youth who meet DSM criteria for Alcohol Dependence may also meet criteria for
             Marijuana Abuse or Dependence and other Drug Abuse

          -  Youth who meet DSM criteria for Alcohol Abuse, may also meet criteria for Marijuana or
             other Drug Abuse

          -  Live within a 30-minute drive of the clinic

        Exclusion Criteria:

          -  Meet DSM criteria for Drug Dependence (other than Marijuana Dependence)

          -  Meet DSM criteria for Alcohol Abuse with Marijuana Dependence. Use of other drugs will
             not be excluded

          -  Participants will also be excluded if they exhibit an active psychosis

          -  Have a severe medical or psychiatric illness that will limit participation

          -  Are pregnant or breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Stanger, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geisel School of Medicine at Dartmouth</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Stanger C, Scherer EA, Babbin SF, Ryan SR, Budney AJ. Abstinence based incentives plus parent training for adolescent alcohol and other substance misuse. Psychol Addict Behav. 2017 Jun;31(4):385-392. doi: 10.1037/adb0000279. Epub 2017 Apr 17.</citation>
    <PMID>28414474</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2008</study_first_submitted>
  <study_first_submitted_qc>January 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2008</study_first_posted>
  <results_first_submitted>October 30, 2017</results_first_submitted>
  <results_first_submitted_qc>March 1, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 29, 2018</results_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Catherine Stanger</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>(MET)/CBT+CM/BPT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT
Motivational Enhancement Therapy (MET)/CBT+CM: Behavioral Treatment</description>
        </group>
        <group group_id="P2">
          <title>(MET)/CBT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT
Motivational Enhancement Therapy (MET)/CBT: Behavioral Treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Treatment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>36-week Follow-up Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>(MET)/CBT+CM/BPT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT
Motivational Enhancement Therapy (MET)/CBT+CM: Behavioral Treatment</description>
        </group>
        <group group_id="B2">
          <title>(MET)/CBT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT
Motivational Enhancement Therapy (MET)/CBT: Behavioral Treatment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.1" spread="1.2"/>
                    <measurement group_id="B2" value="16.2" spread="1.2"/>
                    <measurement group_id="B3" value="16.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco user</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean intake proportion of days used alcohol in past 30 days</title>
          <description>We report the proportion of days used because not all participants provided data for the identical number of days at each assessment. Therefore the denominator differs across participants, and the proportion of days on which use was reported is the more appropriate measure of use frequency.</description>
          <units>proportion of days used alcohol</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.12" spread="0.16"/>
                    <measurement group_id="B2" value="0.12" spread="0.14"/>
                    <measurement group_id="B3" value="0.12" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean drinks per drinking day</title>
          <units>Drinks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.7" spread="4.9"/>
                    <measurement group_id="B2" value="6.4" spread="4.5"/>
                    <measurement group_id="B3" value="6.0" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>DSM Alcohol Use Disorder</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Dependence</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Abuse only</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>None</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Alcohol Abstinence</title>
        <description>Number of non-abstinent urinalysis (ETG-positive) samples during 14 weeks of treatment (considering missing samples as non-abstinent)</description>
        <time_frame>Weekly up to 14 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>(MET)/CBT+CM/BPT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT
Motivational Enhancement Therapy (MET)/CBT+CM: Behavioral Treatment</description>
          </group>
          <group group_id="O2">
            <title>(MET)/CBT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT
Motivational Enhancement Therapy (MET)/CBT: Behavioral Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Alcohol Abstinence</title>
          <description>Number of non-abstinent urinalysis (ETG-positive) samples during 14 weeks of treatment (considering missing samples as non-abstinent)</description>
          <units>Samples</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="3.5"/>
                    <measurement group_id="O2" value="2.6" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.66</p_value>
            <method>Poisson regression</method>
            <method_desc>Chi-square test with 1 degree of freedom</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.80</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.29</ci_lower_limit>
            <ci_upper_limit>2.18</ci_upper_limit>
            <estimate_desc>Odds ratio for 0 ETG-positive samples for MET/CBT+CM/BPT (numerator) vs. MET/CTB (denominator)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.61</p_value>
            <method>Poisson regression</method>
            <method_desc>Chi-square test with 1 degree of freedom</method_desc>
            <param_type>mean ratio</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>1.22</ci_upper_limit>
            <estimate_desc>Mean ratio for number of ETG-positive samples, if &gt;0 ETG-positive samples: MET/CBT+CM/BPT (numerator) vs. MET/CTB (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Days of Alcohol Use During 36-week Follow-up Period</title>
        <description>Percentage of days alcohol used during the 36-week follow-up period after treatment ended measured via timeline follow-back.</description>
        <time_frame>Monthly up to 9 months (36 weeks)</time_frame>
        <population>The analysis population consisted of only participants with follow-up (alcohol use) data on at least 85% of the days in the 36-week follow-up period.</population>
        <group_list>
          <group group_id="O1">
            <title>(MET)/CBT+CM/BPT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT
Motivational Enhancement Therapy (MET)/CBT+CM: Behavioral Treatment</description>
          </group>
          <group group_id="O2">
            <title>(MET)/CBT</title>
            <description>Motivational Enhancement Therapy (MET)/CBT
Motivational Enhancement Therapy (MET)/CBT: Behavioral Treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Days of Alcohol Use During 36-week Follow-up Period</title>
          <description>Percentage of days alcohol used during the 36-week follow-up period after treatment ended measured via timeline follow-back.</description>
          <population>The analysis population consisted of only participants with follow-up (alcohol use) data on at least 85% of the days in the 36-week follow-up period.</population>
          <units>percentage of days used</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="8.8"/>
                    <measurement group_id="O2" value="7.6" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.74</p_value>
            <method>Poisson regression</method>
            <method_desc>Chi-square test with 1 degree of freedom</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.26</ci_lower_limit>
            <ci_upper_limit>2.62</ci_upper_limit>
            <estimate_desc>Odds ratio for 0% days using alcohol during the 36 week follow-up period: MET/CBT+CM/BPT (numerator) vs. MET/CTB (denominator)</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>Poisson regression</method>
            <method_desc>Chi-square test with 1 degree of freedom</method_desc>
            <param_type>mean ratio</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>.59</ci_lower_limit>
            <ci_upper_limit>.92</ci_upper_limit>
            <estimate_desc>Mean ratio for percentage of days with alcohol use during the 36 week follow-up period, if alcohol was used: MET/CBT+CM/BPT (numerator) vs. MET/CTB (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>9 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>(MET)/CBT+CM/BPT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT+CM/BPT
Motivational Enhancement Therapy (MET)/CBT+CM: Behavioral Treatment</description>
        </group>
        <group group_id="E2">
          <title>(MET)/CBT</title>
          <description>Motivational Enhancement Therapy (MET)/CBT
Motivational Enhancement Therapy (MET)/CBT: Behavioral Treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Catherine Stanger, Ph.D.</name_or_title>
      <organization>Dartmouth College</organization>
      <phone>603-646-7023</phone>
      <email>catherine.stanger@dartmouth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

